blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3224276

EP3224276 - NOVEL EPITOPE AS A TARGET FOR THERAPY OF INFLAMMATORY AUTOIMMUNE DISEASES AND GRAFT REJECTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.04.2021
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  15.05.2020
FormerGrant of patent is intended
Status updated on  09.05.2020
FormerExamination is in progress
Status updated on  25.02.2020
FormerGrant of patent is intended
Status updated on  17.10.2019
FormerExamination is in progress
Status updated on  05.02.2019
FormerRequest for examination was made
Status updated on  01.09.2017
FormerThe international publication has been made
Status updated on  16.06.2017
Most recent event   Tooltip15.07.2022Lapse of the patent in a contracting state
New state(s): BE		published on 17.08.2022  [2022/33]
Applicant(s)For all designated states
Technion Research & Development Foundation Limited
Senate House
Technion City
3200004 Haifa / IL
[2019/10]
Former [2017/40]For all designated states
Rappaport Family Institute for Research in the Medical Sciences
1 Efron Street
P.O.Box 9697
3109602 Haifa / IL
Inventor(s)01 / KARIN, Nathan
9 Caspari Street
3467703 Haifa / IL
02 / WILDBAUM, Gizi
3 Mairon Street
2903649 Kiryat Yam / IL
 [2017/40]
Representative(s)Pearl Cohen Zedek Latzer Baratz UK LLP
The Gridiron Building
One Pancras Square
London N1C 4AG / GB
[2020/25]
Former [2017/40]Pearl Cohen Zedek Latzer Baratz UK LLP
16 Upper Woburn Place
London WC1H 0BS / GB
Application number, filing date15863095.417.11.2015
[2017/40]
WO2015IL51107
Priority number, dateUS201462083952P25.11.2014         Original published format: US 201462083952 P
[2017/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016084062
Date:02.06.2016
Language:EN
[2016/22]
Type: A1 Application with search report 
No.:EP3224276
Date:04.10.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 02.06.2016 takes the place of the publication of the European patent application.
[2017/40]
Type: B1 Patent specification 
No.:EP3224276
Date:17.06.2020
Language:EN
[2020/25]
Search report(s)International search report - published on:IL02.06.2016
(Supplementary) European search report - dispatched on:EP04.04.2018
ClassificationIPC:C07K14/705, C07K7/06, C07K16/28, A61K39/395, A61K38/17, G01N33/50, A61P37/06, A61P37/00, A61P29/00
[2018/18]
CPC:
C07K16/28 (EP,US); C07K7/06 (US); A61K38/17 (EP,US);
A61K39/395 (US); A61P29/00 (EP,US); A61P37/00 (EP,US);
A61P37/06 (EP,US); C07K14/705 (EP,US); G01N33/564 (EP,US);
A61K2039/505 (EP,US); A61K38/00 (EP,US); C07K14/435 (US);
C07K16/00 (US); C07K2317/33 (EP,US) (-)
Former IPC [2017/40]C07K14/705, C07K7/06, C07K16/28, A61K39/395, A61K38/17
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/40]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:NEUARTIGES EPITOP ALS TARGET ZUR THERAPIE VON ENTZÜNDLICHEN AUTOIMMUNKRANKHEITEN UND TRANSPLANTATABSTOSSUNG[2017/40]
English:NOVEL EPITOPE AS A TARGET FOR THERAPY OF INFLAMMATORY AUTOIMMUNE DISEASES AND GRAFT REJECTION[2017/40]
French:NOUVEL ÉPITOPE EN TANT QUE CIBLE POUR LA THÉRAPIE DE MALADIES INFLAMMATOIRES AUTO-IMMUNES ET DU REJET DE GREFFE[2017/40]
Entry into regional phase15.06.2017National basic fee paid 
15.06.2017Search fee paid 
15.06.2017Designation fee(s) paid 
15.06.2017Examination fee paid 
Examination procedure15.06.2017Examination requested  [2017/40]
15.06.2017Date on which the examining division has become responsible
22.10.2018Amendment by applicant (claims and/or description)
08.02.2019Despatch of a communication from the examining division (Time limit: M04)
13.06.2019Reply to a communication from the examining division
18.10.2019Communication of intention to grant the patent
21.02.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
21.02.2020Fee for grant paid
21.02.2020Fee for publishing/printing paid
08.05.2020Information about intention to grant a patent
08.05.2020Receipt of the translation of the claim(s)
Opposition(s)18.03.2021No opposition filed within time limit [2021/21]
Fees paidRenewal fee
10.01.2018Renewal fee patent year 03
22.11.2018Renewal fee patent year 04
23.01.2020Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.11.201703   M06   Fee paid on   10.01.2018
30.11.201905   M06   Fee paid on   23.01.2020
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.11.2015
AL17.06.2020
AT17.06.2020
CY17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
ES17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
MK17.06.2020
MT17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
TR17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
IE17.11.2020
LU17.11.2020
BE30.11.2020
CH30.11.2020
LI30.11.2020
[2022/33]
Former [2022/32]HU17.11.2015
AL17.06.2020
AT17.06.2020
CY17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
ES17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
MK17.06.2020
MT17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
TR17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
IE17.11.2020
LU17.11.2020
CH30.11.2020
LI30.11.2020
Former [2022/27]HU17.11.2015
AL17.06.2020
AT17.06.2020
CY17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
ES17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
MT17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
TR17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
IE17.11.2020
LU17.11.2020
CH30.11.2020
LI30.11.2020
Former [2021/46]AL17.06.2020
AT17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
ES17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
IE17.11.2020
LU17.11.2020
CH30.11.2020
LI30.11.2020
Former [2021/37]AL17.06.2020
AT17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
ES17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
LU17.11.2020
CH30.11.2020
LI30.11.2020
Former [2021/33]AL17.06.2020
AT17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
ES17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
LU17.11.2020
Former [2021/31]AL17.06.2020
AT17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
ES17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
Former [2021/24]AL17.06.2020
AT17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
ES17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
Former [2021/21]AL17.06.2020
AT17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
ES17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
Former [2021/10]AL17.06.2020
AT17.06.2020
CZ17.06.2020
EE17.06.2020
ES17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
Former [2021/09]AL17.06.2020
AT17.06.2020
CZ17.06.2020
EE17.06.2020
ES17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
NL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
PT19.10.2020
Former [2021/04]AL17.06.2020
FI17.06.2020
HR17.06.2020
LT17.06.2020
LV17.06.2020
NL17.06.2020
RS17.06.2020
SE17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
Former [2021/01]FI17.06.2020
HR17.06.2020
LT17.06.2020
LV17.06.2020
RS17.06.2020
SE17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
Former [2020/51]FI17.06.2020
HR17.06.2020
LT17.06.2020
LV17.06.2020
RS17.06.2020
SE17.06.2020
NO17.09.2020
GR18.09.2020
Former [2020/50]FI17.06.2020
HR17.06.2020
LT17.06.2020
LV17.06.2020
SE17.06.2020
NO17.09.2020
GR18.09.2020
Former [2020/48]FI17.06.2020
LT17.06.2020
SE17.06.2020
NO17.09.2020
Former [2020/47]LT17.06.2020
NO17.09.2020
Documents cited:Search[XY]US2006035834  (KARIN NATHAN [IL]) [X] 1-15 * the whole document * * paragraphs [[59]] , [ [67]] , [ [71]]; claims 1-27 * [Y] 1-15;
 [Y]WO2014033266  (INST NAT SANTE RECH MED [FR], et al) [Y] 1-15* the whole document *
International search[X]WO2004041179  (US HEALTH [US], et al) [X] 10, 15-20, 25-27, 29-33, 37 * pages 12-15 *;
 [X]US2006194265  (MORRIS DAVID W [US], et al) [X] 1-8, 10-31, 38, 39 * SEQ ID NO: 982, claims 22, 27, 37, 38-39 *;
 [X]WO2011086001  (CORMUS SRL [IT], et al) [X] 10, 15-20* page 11 lines 23-27 *
 [X]  - "http://www.ncbi.nlm.nihgov/protein/CAA80277.1", NCBI - GenBank, (20040909), Database accession no. CAA80277.1 [X] 42,43 * DATABASE NCBI [Online] 9-9-2004 CLA-1 [Homo sapiens] GenBank accession number: CAA80277.1 URL: http://www.ncbi.nlm.nihgov/protein/CAA80277.1 09 Sep 2004 (2004/09/09) the whole document *
by applicantUS4036945
 US4331647
 US4816567
 US4946778
 US5545807
 US5545806
 US5569825
 US5625126
 US5633425
 US5661016
 WO2004041179
    - BOOTH et al., Immunol. Lett., (19880000), vol. 19, pages 65 - 70
    - GARDELLA et al., J. Biol. Chem., vol. 265, pages 15854 - 15859
    - PRESTA, Curr. Op. Struct. Biol., (19920000), vol. 2, pages 593 - 596
    - BOWIE et al., Science, (19900000), vol. 247, page 1306 1310
    - JONES et al., Nature, (19860000), vol. 321, pages 522 - 525
    - TRAMONTANOSCHLOEDER, Methods in Enzymology, (19890000), vol. 178, pages 551 - 568
    - PORTER, R. R., Biochem. J., (19590000), vol. 73, pages 119 - 126
    - INBAR et al., Proc. Nat'l Acad. Sci. USA, (19720000), vol. 69, pages 2659 - 62
    - WHITLOWFILPULA, Methods, (19910000), vol. 2, pages 97 - 105
    - VERHOEYEN et al., Science, (19880000), vol. 239, pages 1534 - 1536
    - PACK et al., Bio/Technology, (19930000), vol. 11, pages 1271 - 77
    - Larrick and Fry Methods, (19910000), vol. 2, pages 106 - 10
    - RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 327
    - HOOGENBOOMWINTER, J. Mol. Biol., (19910000), vol. 222, page 581
    - COLE et al., Monoclonal Antibodies and Cancer Therapy, (19850000), page 77
    - BOERNER et al., J. Immunol., (19910000), vol. 147, no. 1, pages 86 - 95
    - MARKS et al., Bio/Technology, (19920000), vol. 10, pages 779 - 783
    - LONBERG et al., Nature, (19940000), vol. 368, pages 812 - 859
    - FISHWILD et al., Nature Biotechnology, (19960000), vol. 14, pages 826 - 51
    - LONBERGHUSZAR, Intern. Rev. Immunol., (19950000), vol. 13, pages 65 - 93
    - BRISSON et al., Nature, (19840000), vol. 310, pages 511 - 514
    - BITTER et al., Methods in Enzymol., (19870000), vol. 153, pages 516 - 544
    - STUDIER et al., Methods in Enzymol., (19900000), vol. 185, pages 60 - 89
    - TAKAMATSU et al., EMBO J., (19870000), vol. 6, pages 307 - 311
    - CORUZZI et al., EMBO J., (19840000), vol. 3, pages 1671 - 1680
    - BROGLI et al., Science, (19840000), vol. 224, pages 838 - 843
    - GURLEY et al., Mol. Cell. Biol., (19860000), vol. 6, pages 559 - 565
    - WEISSBACHWEISSBACH, Methods for Plant Molecular Biology, Academic Press, (19880000), pages 421 - 463
    - FINGL et al., The Pharmacological Basis of Therapeutics, (19750000), page l
    - KRENN V. et al., Histol Histopathol, (20000700), vol. 15, no. 3, page 791
    - JAN VOSWINKEL et al., Arthritis Res, (20010000), vol. 3, no. 3, page 189
    - ERIKSON J. et al., Immunol Res, (19980000), vol. 17, no. 1-2, page 49
    - RENAUDINEAU Y. et al., Clin Diagn Lab Immunol, (19990300), vol. 6, no. 2, page 156
    - CHAN OT et al., Immunol Rev, (19990600), vol. 169, page 107
    - ZIMMET P, Diabetes Res Clin Pract, (19961000), vol. 34, page S125
    - ORGIAZZI J, Endocrinol Metab Clin North Am, (20000600), vol. 29, no. 2, page 339
    - BRALEY-MULLEN HYU S, J Immunol, (20001215), vol. 165, no. 12, page 7262
    - TOYODA N et al., Nippon Rinsho, (19990800), vol. 57, no. 8, page 1759
    - GARZA KM et al., J Reprod Immunol, (19980200), vol. 37, no. 2, page 87
    - DIEKMAN AB et al., Am J Reprod Immunol, (20000300), vol. 43, no. 3, page 134
    - MATSUURA E et al., Lupus, (19980000), vol. 7, no. 2, pages S132 - 9
    - CROSS AH et al., J Neuroimmunol, (20010101), vol. 112, no. 1-2, page 1
    - ORON L et al., J Neural Transm Suppl, (19970000), vol. 49, page 77
    - INFANTE AJKRAIG E, Int Rev Immunol, (19990000), vol. 18, no. 1-2, page 83
    - KORNBERG AJ, J Clin Neurosci, (20000500), vol. 7, no. 3, page 191
    - TAKAMORI M, Am J Med Sci, (20000400), vol. 319, no. 4, page 204
    - ANTOINE JCHONNORAT J, Rev Neurol, (20000100), vol. 156, no. 1, page 23
    - NOBILE-ORAZIO E et al., Electroencephalogr Clin Neurophysiol Suppl, (19990000), vol. 50, page 419
    - VINCENT A et al., Ann N Y Acad Sci, (19980513), vol. 841, page 482
    - PRAPROTNIK S et al., Wien Klin Wochenschr, (20000825), vol. 112, no. 15-16, page 660
    - LACROIX-DESMAZES S et al., Semin Thromb Hemost, (20000000), vol. 26, no. 2, page 157
    - NOEL LH, Ann Med Interne, (20000500), vol. 151, no. 3, page 178
    - FLAMHOLZ R et al., J Clin Apheresis, (19990000), vol. 14, no. 4, page 171
    - WALLUKAT G. et al., Am J Cardiol, (19990617), vol. 83, no. 12A, page 75H
    - MOCCIA F, Ann Ital Med Int., (19990400), vol. 14, no. 2, page 114
    - EFREMOV DG et al., Leuk Lymphoma, (19980100), vol. 28, no. 3-4, page 285
    - GARCIA HEROLA A et al., Gastroenterol Hepatol, (20000100), vol. 23, no. 1, page 16
    - LANDAU YESHOENFELD Y, Harefuah, (20000116), vol. 138, no. 2, page 122
    - FEIST E et al., Int Arch Allergy Immunol, (20000900), vol. 123, no. 1, page 92
    - ZAULI D et al., Biomed Pharmacother, (19990600), vol. 53, no. 5-6, page 234
    - MANNS MP, J Hepatol, (20000800), vol. 33, no. 2, page 326
    - STRASSBURG CP et al., Eur J Gastroenterol Hepatol, (19990600), vol. ll, no. 6, page 595
    - TISCH RMCDEVITT HO, Proc Natl Acad Sci U S A, (19940118), vol. 91, no. 2, page 437
    - CASTANO LEISENBARTH GS, Ann. Rev. Immunol., vol. 8, page 647
    - SAKATA S et al., Mol Cell Endocrinol, (19930300), vol. 92, no. 1, page 77
    - ALEXANDER RB et al., Urology, (19971200), vol. 50, no. 6, page 893
    - HARA T et al., Blood, (19910301), vol. 77, no. 5, page 1127
    - SODERSTROM M et al., J Neurol Neurosurg Psychiatry, (19940500), vol. 57, no. 5, page 544
    - OSHIMA M et al., Eur J Immunol, (19901200), vol. 20, no. 12, page 2563
    - HIEMSTRA HS et al., Proc Natl Acad Sci U S A, (20010327), vol. 98, no. 7, page 3988
    - CUNHA-NETO E et al., J Clin Invest, (19961015), vol. 98, no. 8, page 1709
    - SEMPLE JW et al., Blood, (19960515), vol. 87, no. 10, page 4245
    - CAPOROSSI AP et al., Viral Immunol, (19980000), vol. 11, no. 1, page 9
    - SALLAH S et al., Ann Hematol, (19970300), vol. 74, no. 3, page 139
    - FRANCO A et al., Clin Immunol Immunopathol, (19900300), vol. 54, no. 3, page 382
    - JONES DE, Clin Sci (Colch, (19961100), vol. 91, no. 5, page 551
    - KELLY CJ, J Am Soc Nephrol, (19900800), vol. l, no. 2, page 140
    - YOO TJ et al., Cell Immunol, (19940800), vol. 157, no. 1, page 249
    - GLODDEK B et al., Ann N Y Acad Sci, (19971229), vol. 830, no. 266, page 266
    - MOCCIA F, Ann Ital Med Int, (19990400), vol. 14, no. 2, page 114
    - TISCH RMCDEVITT HO, Proc Natl Acad Sci units S A, (19940118), vol. 91, no. 2, page 437
    - HIEMSTRA HS et al., Proc Natl Acad Sci units S A, (20010327), vol. 98, no. 7, page 3988
    - POLMAN et al., Ann Neurol, (20050000), vol. 58, pages 840 - 846
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.